glp 1 news The GLP-1 revolution: What UAB researchers are discovering about how these drugs work A wave of new #GLP1

yet about 12% of U.S

Clinicians have reported using GLP-1RAs to short-circuit addictions to gambling and sex

For patients interested in natural ways to support their GLP-1 levels, certain dietary strategies can help

Compounding the problem is the fact that insurance companies are reluctant to cover these anti-obesity medications, since theyre considered by many to be vanity drugs, even though overwhelming evidence suggests obesity is linked directly to multiple comorbidities

Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management